Hangzhou DAC Biotechnology Co., Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   DXC006 With Immune Checkpoint Inhibitors or Platinum for Small…DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer

   Recruitment opened

   Hangzhou DAC Biotechnology Co., Ltd.·Phase 1/2· NCT07559929· Registry history of NCT07559929 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

2. Notable

   DEC003M in Prostate Cancer

   Recruitment opened

   And 1 more change in the last 30 days

   Hangzhou DAC Biotechnology Co., Ltd.·Phase 1· NCT07657806· Registry history of NCT07657806 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.